Information:
Fel:
ID
31060
Beskrivning
Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT01099124
Länk
https://clinicaltrials.gov/show/NCT01099124
Nyckelord
Versioner (1)
- 2018-07-16 2018-07-16 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
16 juli 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Non Small Cell Lung Cancer NCT01099124
Eligibility Non Small Cell Lung Cancer NCT01099124
- StudyEvent: Eligibility
Similar models
Eligibility Non Small Cell Lung Cancer NCT01099124
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
1. aged 18-70 years old;
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma TNM clinical staging | Therapy naive | Prior Chemotherapy Without TC Regimen
Item
2. patients with ⅲ/ⅳ nsclc confirmed by histopathology or cytology who ware naive or previous chemotherapy without tc regimen;
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0919936 (UMLS CUI [2])
C1514457 (UMLS CUI [3,1])
C0332288 (UMLS CUI [3,2])
C4522122 (UMLS CUI [3,3])
C3258246 (UMLS CUI [1,2])
C0919936 (UMLS CUI [2])
C1514457 (UMLS CUI [3,1])
C0332288 (UMLS CUI [3,2])
C4522122 (UMLS CUI [3,3])
Medical contraindication Absent Chemotherapy
Item
3. no contraindication for chemotherapy;
boolean
C1301624 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
ECOG performance status
Item
4. ecog performance scale 0-2;
boolean
C1520224 (UMLS CUI [1])
Antiangiogenesis therapy Absent
Item
5. no history of anti-angiogenesis therapy;
boolean
C0281318 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,2])
Informed Consent
Item
6. patients are voluntary to participate and sigh the informed contents.
boolean
C0021430 (UMLS CUI [1])
Antineoplastic Agents
Item
1. concurrent use of other anti-cancer agents;
boolean
C0003392 (UMLS CUI [1])
Hypersensitivity M2ES | Hypersensitivity Biological Factors
Item
2. allergic history to m2es and biological agents;
boolean
C0020517 (UMLS CUI [1,1])
C2985192 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0005515 (UMLS CUI [2,2])
C2985192 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0005515 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
3. pregnant or breast-feeding women;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Cancer Other
Item
4. with other malignancy;
boolean
C1707251 (UMLS CUI [1])
Cor pulmonale Severe
Item
5. with severe cardiopulmonary disease;
boolean
C0034072 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain Uncontrolled
Item
6. uncontrolled brain metastasis patients;
boolean
C0220650 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
Condition Study Subject Participation Status Exclusion
Item
7. other conditions that are regarded for exclusion by the trialists.
boolean
C0348080 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])